476040 — OrganoidSciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for OrganoidSciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	30,559	30,429	22,003	16,017
Net Total Accounts Receivable
Net Total Receivables	2,053	389	816	404
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32,960	31,136	23,373	16,898
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,148	7,381	7,874	7,212
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	37,282	39,760	32,755	25,892
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	50,977	75,231	104,934	5,051
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	53,245	79,320	110,093	10,580
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-15,962	-39,560	-77,338	15,313
Total Liabilities & Shareholders' Equity	37,282	39,760	32,755	25,892
Total Common Shares Outstanding